Yu De-min, Li Ming-zhen, Liu De-min
Metabolic Disease Hospital, Tianjin Medical University, Tianjin, 300070 PR China.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2005 Feb;22(1):14-7.
To investigate the prevalence of mitochondrial DNA (mtDNA) mutations in patients with early-onset diabetes in Tianjin, and to explore the relationship between mtDNA mutations and diabetes.
348 non-related patients whose age at onset of diabetes was less than 45 years were randomly recruited, and 207 non-related and non-diabetic subjects were enrolled as controls. All their clinical and biochemical data were collected. Total genome was extracted conventionally from the participants' peripheral leucocytes, and polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and cloning techniques were applied to the screening of mtDNA mutations (including the 3316, 3394 and 3426 in ND1 region, 12026 in ND4 region, and tRNA [Leu(UUR)] 3243 A-->G mutation).
The authors found 17 diabetics harboring the 12026 A-->G mutation in ND4 region (4.9%), 10 diabetics with mutations in ND1 region (including 5 diabetics with the 3394 T-->C mutation, 4 diabetics with 3316 G-->A mutation, one with 3426 A-->G mutation), and only two with the known 3243 A-->G mutation (0.6%). On the contrary, one control subject with the 3316 G-->A mutation, two with 3394 T-->C mutation and four with 12026 A-->G mutation were found. The prevalence of mtDNA mutations in the patient group is significantly higher than that in the control group (3.3%) (P<0.05).
The above findings suggest that mtDNA mutation may be implicated in the pathogenesis of the examined diabetes.
调查天津早发糖尿病患者线粒体DNA(mtDNA)突变的发生率,并探讨mtDNA突变与糖尿病之间的关系。
随机招募348例糖尿病发病年龄小于45岁的非亲属患者,并纳入207例非亲属非糖尿病受试者作为对照。收集所有受试者的临床和生化数据。常规从受试者外周血白细胞中提取全基因组,应用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)和克隆技术筛选mtDNA突变(包括ND1区域的3316、3394和3426位点,ND4区域的12026位点,以及tRNA[Leu(UUR)]3243 A→G突变)。
作者发现17例糖尿病患者在ND4区域存在12026 A→G突变(4.9%),10例糖尿病患者在ND1区域存在突变(包括5例3394 T→C突变、4例3316 G→A突变、1例3426 A→G突变),仅2例存在已知的324 A→G突变(0.6%)。相反,在对照组中发现1例3316 G→A突变、2例3394 T→C突变和4例12026 A→G突变。患者组mtDNA突变的发生率显著高于对照组(3.3%)(P<0.05)。
上述结果提示mtDNA突变可能参与了所研究糖尿病的发病机制。